 |
|
|
|
 Marine Natural Products as Anti-Cancer Compounds
Phil Crews, Dept. of Chemistry and Biochemistry
The Crews laboratory investigates the chemical structure and biological activity of chemical compounds that are derived from marine organisms. Among its many research projects, the laboratory collaborates with scientists at other research institutions and pharmaceutical industries to explore the identification and development of naturally occuring compunds in the fight against cancer. [More]
|
 Lipooxygenase Inhibitors as Potential Anti-Cancer Drugs
Ted Holman, Dept. of Chemistry & Biochemistry
Lipoxygenases are enzymes implicated in a broad range of human cancers, as well as cardiac and inflammatory diseases. Ted Holman's laboratory examines the enzymatic mechanism and biological function of lipoxygenase in the hopes of developing novel inhibitors. In collaboration with UCSC Professor Phil Crews, his laboratory has identified potent lipoxygenase inhibitors and are currently characterizing their structure/function reactivity. The results of this work will shed light on their potential as anti-cancer agents. [More]
|
 Drugs from the Sea: Marine Natural Products as Chemical Probes
Roger Linington, Dept. of Chemistry and Biochemistry
Dr. Linington’s natural products and organic chemistry lab focuses on two complimentary areas of neglected infectious disease research: identification of novel drug leads against malaria and cholera, and development of natural products as chemical probes to explore questions of basic biochemistry in the arena of parasitology. Natural products are a crucial component of todays therapeutic arsenal and exploration of the diversity present in microbes from marine sediments represents an exciting new avenue for contemporary drug discovery. [More]
|
Chemical Genetics
Scott Lokey, Dept. of Chemistry and Biochemistry
The laboratory of Scott Lokey uses a small molecule approach, called chemical genetics, to study signaling pathways related to cell cycle checkpoints and the actin cytoskeleton. In one study, Lokey and his co-workers are developing screens of natural compounds that can be used to examine how cells detect their own DNA damage. Studies such as these might lead to development of a new class of chemotherapeutic agents. [More]
|
Chemical Genetic-based Cancer Therapies
William Sullivan, Dept. of MCD Biology
In order to understand the molecular and cellular events guiding the initial nuclear divisions of the Drosophila embryo, the Sullivan laboratory carries out screens for mutations that specifically disrupt syncytial divisions. These screens have yielded mutations in conserved cell cycle checkpoint genes. Their findings suggest new strategies for destroying checkpoint-compromised cancer cells and have enabled them to develop in vivo screens for anti-cancer reagents. [More]
|
|
